BLOOD TYPE O IS A RISK FACTOR FOR HYPERFIBRINOLYSIS AND MASSIVE TRANSFUSION AFTER SEVERE INJURY

被引:9
作者
DeBot, Margot [1 ]
Eitel, Andrew P. [1 ]
Moore, Ernest E. [1 ,2 ]
Sauaia, Angela [1 ,3 ]
Lutz, Patrick [1 ]
Schaid, Terry R. [1 ]
Hadley, Jamie B. [1 ]
Kissau, Daniel J. [1 ]
Cohen, Mitchell J. [1 ]
Kelher, Marguerite R. [1 ]
Silliman, Christopher C. [1 ,4 ,5 ,6 ]
机构
[1] Univ Colorado Denver, Trauma Res Ctr, Sch Med, Dept Surg, Aurora, CO USA
[2] Denver Hlth, Dept Surg, Ernest E Moore Shock Trauma Ctr, Denver, CO USA
[3] Univ Colorado Denver, Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA
[4] Vitalant Res Inst, Denver, CO USA
[5] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA
[6] Vitalant Res Inst, 717 Yosemite St, Denver, CO 80230 USA
来源
SHOCK | 2022年 / 58卷 / 06期
基金
美国国家卫生研究院;
关键词
Blood type O; hyperfibrinolysis; massive transfusion; trauma-induced coagulopathy; VON-WILLEBRAND-FACTOR; FIBRINOLYSIS SHUTDOWN; POSTINJURY FIBRINOLYSIS; TRAUMA; MORTALITY; RESUSCITATION; RATIONALE; IMPACT;
D O I
10.1097/SHK.0000000000002013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Blood type O is the most common blood type and has lower von Willebrand factor (vWF) levels (25%-35% lower than non-O blood types). von Willebrand factor is important for initiating platelet attachment and binding factor VIII. We hypothesized that patients with type O blood are at an increased risk of trauma-induced coagulopathy and bleeding post injury. Study Design: Adult trauma activations with known blood type at a level I trauma center with field systolic blood pressure < 90 mm Hg were studied retrospectively. The relationships of blood group O versus non-O to coagulation assays, massive transfusion (MT), ventilator-free days, and mortality were adjusted for confounders. Hyperfibrinolysis (HF) was defined as thromboelastogram of percent lysis in 30 min > 3%, and fibrinolysis shutdown was defined as percent lysis in 30 min < 0.9%. von Willebrand factor activity was quantified on 212 injured patients using a STAGO apparatus. Results: Overall, 268 patients met criteria. Type O patients were more likely to develop HF than non-type O blood patients (43% vs. 29%, P = 0.06) and had significantly lower vWF activity (222% vs. 249%, P = 0.01). After adjustment for New Injury Severity Score and blunt mechanism, type O had higher odds of HF (odds ratio, 1.94, 95% confidence interval, 1.09-3.47) and increased odds of MT (odds ratio, 3.02; 95% confidence interval, 1.22-7.49). Other outcomes were not significantly affected. Conclusion: Type O patients with hypotension had increased HF and MT post injury, and these were associated with lower vWF activity. These findings have implications for the monitoring of HF in patients receiving type O whole-blood transfusions post injury.
引用
收藏
页码:492 / 497
页数:6
相关论文
共 30 条
  • [11] Role of Fibrinogen in Trauma-Induced Coagulopathy
    Meizoso, Jonathan P.
    Moore, Ernest E.
    Pieracci, Fredric M.
    Saberi, Rebecca A.
    Ghasabyan, Arsen
    Chandler, James
    Namias, Nicholas
    Sauaia, Angela
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (04) : 465 - 473
  • [12] Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network
    Miszta, Adam
    Pelkmans, Leonie
    Lindhout, Theo
    Krishnamoorthy, Ganeshram
    de Groot, Philip G.
    Hemker, Coenraad H.
    Heemskerk, Johan W. M.
    Kelchtermans, Hilde
    de Laat, Bas
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (52) : 35979 - 35986
  • [13] Montgomery RR., 2001, WILLEBRAND DISIEASE, P115
  • [14] Trauma-induced coagulopathy
    Moore, Ernest E.
    Moore, Hunter B.
    Kornblith, Lucy Z.
    Neal, Matthew D.
    Hoffman, Maureane
    Mutch, Nicola J.
    Schoechl, Herbert
    Hunt, Beverley J.
    Sauaia, Angela
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [15] Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient
    Moore, Ernest E.
    Moore, Hunter B.
    Gonzalez, Eduardo
    Sauaia, Angela
    Banerjee, Anirban
    Silliman, Christopher C.
    [J]. TRANSFUSION, 2016, 56 : S110 - S114
  • [16] Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid
    Moore, Ernest E.
    Moore, Hunter B.
    Gonzalez, Eduardo
    Chapman, Michael P.
    Hansen, Kirk C.
    Sauaia, Angela
    Silliman, Christopher C.
    Banerjee, Anirban
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2015, 78 : S65 - S69
  • [17] Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial
    Moore, Hunter B.
    Moore, Ernest E.
    Chapman, Michael P.
    McVaney, Kevin
    Bryskiewicz, Gary
    Blechar, Robert
    Chin, Theresa
    Burlew, Clay Cothren
    Pieracci, Fredric
    West, F. Bernadette
    Fleming, Courtney D.
    Ghasabyan, Arsen
    Chandler, James
    Silliman, Christopher C.
    Banerjee, Anirban
    Sauaia, Angela
    [J]. LANCET, 2018, 392 (10144) : 283 - 291
  • [18] Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients
    Moore, Hunter B.
    Moore, Ernest E.
    Liras, Ioannis N.
    Gonzalez, Eduardo
    Harvin, John A.
    Holcomb, John B.
    Sauaia, Angela
    Cotton, Bryan A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 347 - 355
  • [19] Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock
    Moore, Hunter B.
    Moore, Ernest E.
    Lawson, Peter J.
    Gonzalez, Eduardo
    Fragoso, Miguel
    Morton, Alex P.
    Gamboni, Fabia
    Chapman, Michael P.
    Sauaia, Angela
    Banerjee, Anirban
    Silliman, Christopher C.
    [J]. SURGERY, 2015, 158 (02) : 386 - 392
  • [20] Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: The spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy
    Schreiber, Martin A.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (06) : 817 - 817